Author

Manon G. van der Meer

Observed names: M G Van Der Meer, M G van de Meer, M G van der Meer, M Van Daal, M Van Der Meer, M. G. Van Der Meer, M. G. van de Meer, M. G. van der Meer, M.G. Van Der Meer, M.G. Van der Meer, M.G. van der Meer, Manon G van der Meer, Manon G. Van Der Meer, Manon G. Van der Meer, Manon van der Meer, van der Meer, Manon G, van der Meer, Manon G.

Institutions: Utrecht University, University Medical Center Utrecht

Observed institutions: Utrecht University, University Medical Center Utrecht, Diakonessenhuis hospital, ERN GUARD-Heart

ORCID: 0009-0008-5839-167X

Observed ORCID: 0009-0008-5839-167X

OpenAlex ID: A5061457886

C-Reactive Protein and Risk of Incident Heart Failure in Patients With Cardiovascular Disease

2023 · Pascal M. Burger, Stefan Koudstaal, et al. · Journal of the American College of Cardiology · 164

C-Reactive Protein and Risk of Cardiovascular Events and Mortality in Patients with Various Cardiovascular Disease Locations

2023 · Pascal M. Burger, Aruna D. Pradhan, et al. · The American Journal of Cardiology · 72

Worse outcome in women with STEMI : a systematic review of prognostic studies

2015 · Manon G. van der Meer, Hendrik M. Nathoe, et al. · European Journal of Clinical Investigation · 55

Cohort profile: the Utrecht Cardiovascular Cohort–Second Manifestations of Arterial Disease (UCC-SMART) Study–an ongoing prospective cohort study of patients at high cardiovascular risk in the Netherlands

2023 · Maria C Castelijns, Marga A G Helmink, et al. · BMJ Open · 48

Long-term outcome in men and women after CABG; results from the IMAGINE trial

2015 · Hester M. den Ruijter, Saskia Haitjema, et al. · Atherosclerosis · 47

Evaluation of the cardiac amyloidosis clinical pathway implementation: a real-world experience

2022 · Maaike Brons, Steven A Muller, et al. · European Heart Journal Open · 32

Prognostic Biomarker Soluble ST2 Exhibits Diurnal Variation in Chronic Heart Failure Patients

2020 · Sandra Crnko, Markella I. Printezi, et al. · ESC Heart Failure · 28

Metabolic syndrome and risk of incident heart failure in non-diabetic patients with established cardiovascular disease

2023 · Pascal M. Burger, Stefan Koudstaal, et al. · International Journal of Cardiology · 25

Evaluation of the 2021 ESC Recommendations for Family Screening in Hereditary Transthyretin Cardiac Amyloidosis

2024 · Steven A. Muller, Belén Peiró-Aventin, et al. · European Journal of Heart Failure · 24

Long-term lifestyle change and risk of mortality and Type 2 diabetes in patients with cardiovascular disease

2023 · Nadia E Bonekamp, Frank L J Visseren, et al. · European Journal of Preventive Cardiology · 23

Gender difference in long-term prognosis among patients with cardiovascular disease

2012 · Manon G van der Meer, Maarten J Cramer, et al. · European Journal of Preventive Cardiology · 23

Sex differences in modifiable risk factors for stroke incidence and recurrence: the UCC-SMART study

2024 · Ina Rissanen, Maartje Basten, et al. · Journal of Neurology · 22

The Diagnostic Value of Clinical Symptoms in Women and Men Presenting with Chest Pain at the Emergency Department, a Prospective Cohort Study

2015 · Manon G. van der Meer, Barbra E. Backus, et al. · PLoS ONE · 22

Physical exercise volume, type, and intensity and risk of all-cause mortality and cardiovascular events in patients with cardiovascular disease: a mediation analysis

2023 · Nadia E Bonekamp, Anne M May, et al. · European Heart Journal Open · 21

Cost-effectiveness of Mediterranean diet and physical activity in secondary cardiovascular disease prevention: results from the UCC-SMART cohort study

2024 · Nadia E Bonekamp, Frank L J Visseren, et al. · European Journal of Preventive Cardiology · 19

Individual lifetime benefit from low-dose colchicine in patients with chronic coronary artery disease

2023 · Pascal M Burger, Jannick A N Dorresteijn, et al. · European Journal of Preventive Cardiology · 19

Are there gender disparities in symptom presentation or triage of patients with chest discomfort at primary care out-of-hours services? An observational study

2019 · Manon G. van der Meer, Yolande Appelman, et al. · BMJ Open · 19

The impact of polyvascular disease on long‐term outcome in percutaneous coronary intervention patients

2013 · Manon G. van der Meer, Maarten J. Cramer, et al. · European Journal of Clinical Investigation · 19

Elevated triglycerides are related to higher residual cardiovascular disease and mortality risk independent of lipid targets and intensity of lipid-lowering therapy in patients with established cardiovascular disease

2025 · Pauline C.E. Schuitema, Frank L.J. Visseren, et al. · Atherosclerosis · 18

Socioeconomic disparities and risk of recurrent cardiovascular events and cardiovascular disease-free life expectancy in patients with established cardiovascular disease

2025 · Stella Bijkerk, Frank L J Visseren, et al. · European Journal of Preventive Cardiology · 13

Absence of an increased wall thickness does not rule out cardiac amyloidosis

2024 · Steven A. Muller, Anouk Achten, et al. · Amyloid · 13

Diversity of heart failure phenotypes in transthyretin amyloid cardiomyopathy. More than just heart failure with preserved ejection fraction

2024 · Anouk Achten, Steven A. Muller, et al. · Annals of Medicine · 12

Added Value of Female-Specific Factors Beyond Traditional Predictors for Future Cardiovascular Disease

2016 · Manon G. van der Meer, Yolanda van der Graaf, et al. · Journal of the American College of Cardiology · 11

Dietary habits and compliance with dietary guidelines in patients with established cardiovascular disease

2024 · Nadia E. Bonekamp, Johanna M. Geleijnse, et al. · European Journal of Clinical Nutrition · 10

External validation of bleeding risk models for the prediction of long-term bleeding risk in patients with established cardiovascular disease

2023 · Maria C. Castelijns, Steven H.J. Hageman, et al. · American Heart Journal · 10

Works count: 93

Citation count: 1,089

H-index: 19

I10-index: 29